Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/116486
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorMuliawan, Gregory Kenneth-
dc.date.accessioned2026-01-02T22:00:44Z-
dc.date.available2026-01-02T22:00:44Z-
dc.identifier.urihttps://ows.lib.polyu.edu.hk/s/ows/item/4399-
dc.identifier.urihttp://hdl.handle.net/10397/116486-
dc.language.isoEnglish-
dc.rightsAll rights reserved-
dc.subjectHepatocellular Carcinoma-
dc.subjectTherapeutic Resistance-
dc.subjectTranscobalamin 1-
dc.subjectMolecular Methods-
dc.subjectTherapeutic Strategies-
dc.titleFrom Challenge to Breakthrough: Advancing HCC Treatment-
dc.typeFeature Story-
dc.typeOWS-
dcterms.abstractDriven by the urgent need for better treatments for hepatocellular carcinoma (HCC), Kenneth embarked on a challenging PhD journey at PolyU. His research seeks to uncover new therapeutic targets and understand why HCC resists existing drugs. The path was not easy—Kenneth faced frequent experimental failures and had to adapt quickly to the demanding research environment. With steadfast support from his supervisor Terence, senior Carmen, and lab teammates, Kenneth built resilience and honed his problem-solving skills. PolyU’s advanced facilities and dedicated staff played a key role in his progress. Through conferences and collaborative projects, Kenneth developed strong communication and presentation skills, transforming from a reserved student to a confident researcher. Kenneth’s experiences have prepared him to make a meaningful impact in cancer research, whether in academia or industry, by bridging the gap between clinical needs and innovative solutions.-
dcterms.accessRightsopen access-
dcterms.issued2025-12-
dcterms.LCSHLiver -- Cancer -- Treatment-
dcterms.LCSHDrug resistance in cancer cells-
dcterms.educationalLevelPostgraduate-
Appears in Collections:Outstanding Work by Students
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.